SPR Biosensor Based High-Throughput Screening of Low Molecular Weight Compounds for Interaction with Candida krusei CYP51

Main Article Content

L.A. Kaluzhskiy
T.V. Tsybruk
E.O. Yablokov
O.V. Gnedenko
E.A. Zelepuga
A.A. Kicha
E.P. Kozlovskaya
N.V. Ivanchina
A.A. Gilep
A.S. Ivanov


The opportunistic fungus Candida krusei is the causative agent of nosocomial infections characterized by high mortality and development of resistance to drugs of the azole class. Therefore, develjoment of non-azole antifungal agents against resistant fungal strains is extremly important. Lanosterol 14-alpha demethylase (CYP51) is a well-known antifungal target. The optical SPR biosensor is a universal tool for screening studies in search of new drug prototypes. This paper presents the methodological aspects of high-hroughput SPR based screening of a library of low molecular weight compounds of natural origin for their interaction with C. krusei CYP51. It has been shown that when performing high-throughput screening, a researcher should pay special attention to the degree of a sensorgram curvature in the association phase. The described approaches to the analysis of high throughput screening data can be useful for researchers working with SPR biosensors from various manufacturers.

Article Details

How to Cite
Kaluzhskiy, L., Tsybruk, T., Yablokov, E., Gnedenko, O., Zelepuga, E., Kicha, A., Kozlovskaya, E., Ivanchina, N., Gilep, A., & Ivanov, A. (2023). SPR Biosensor Based High-Throughput Screening of Low Molecular Weight Compounds for Interaction with Candida krusei CYP51. Biomedical Chemistry: Research and Methods, 6(1), e00183. https://doi.org/10.18097/BMCRM00183


  1. Mastromarino P., Vitali B., Mosca L. (2013) Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol., 36(3), 229-238.
  2. Forastiero A., Garcia-Gil V., Rivero-Menendez O., Garcia-Rubio R., Monteiro M.C., Alastruey-Izquierdo A., Jordan R., Agorio I., Mellado E. (2015) Rapid development of Candida krusei echinocandin resistance during caspofungin therapy. Antimicrob. Agents Chemother., 59(11), 6975-6982. DOI
  3. Choi H.K., Jeong S.J., Lee H.S., Chin B.S., Choi S.H., Han S.H., Kim M.S., Kim C.O., Choi J.Y., Song Y.G., Kim J.M. (2009) Blood stream infections by Candida glabrata and Candida krusei: a single-center experience. Korean J. Intern. Med., 24(3):263-269. DOI
  4. Pfaller M.A., Diekema D.J., Gibbs D.L., Newell V.A., Nagy E., Dobiasova S., Rinaldi M., Barton R., Veselov A. (2008) Global antifungal surveillance group. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol., 46(2), 515-21. DOI
  5. Zhang J., Li L., Lv Q., Yan L., Wang Y., Jiang Y. (2019) The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors. Front Microbiol., 10, 691. DOI
  6. Hou X., Sun M., Bao T., Xie X., Wei F., Wang S. (2020) Recent advances in screening active components from natural products based on bioaffinity techniques. Acta Pharm. Sin B., 10(10), 1800-1813. DOI
  7. Strushkevich N., Usanov S.A., Park H.W. (2010) Structural basis of human CYP51 inhibition by antifungal azoles. J. Mol. Biol., 397(4), 1067-1078. DOI
  8. Kaluzhskiy L., Ershov P., Shkel T., Gnedenko O., Ivanchina N., Strushkevich N., Kicha A., Grabovec I., Gilep A., Usanov S., Stonik V., Ivanov A. (2018). Application of the SPR biosensor in drug prototypes discovery with human cytochrome P450(51) as an example. Biomedical Chemistry: Research and Methods, 1(4), e00055. DOI
  9. Johnsson B., Löfås S., Lindquist G. (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem., 198(2), 268-277. DOI
  10. Murray J.B., Roughley S.D., Matassova N., Brough P.A. (2014) Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products. J. Med. Chem., 57(7), 2845-2850. DOI